Uroalerts Men's Health Weekly

June 09, 2026

Videos

Peer-to-Peer Clinical Conversations

Five-Year Outcomes and Retreatment Rates Following Prostate Artery Embolization - Diana Lopategui

Diana Lopategui reviews a Danish nationwide prospective cohort of 336 patients undergoing prostatic artery embolization from 2017-2022.

Review of Urosymphyseal Fistula: Pathogenesis, Imaging, and a Multidisciplinary Treatment Algorithm - Claire Haas & Hiren Patel

Hiren Patel

Claire Haas and Hiren Patel discuss urosymphyseal fistula management with Alan Wein.

Beyond the Abstracts

Automated Classification of Adverse Events after Hydrogel Perirectal Spacer Insertion for Prostate Cancer Using Large Language Models - Beyond the Abstract

Zip Code, Race, and Ethnicity: The Impact of Socioeconomic Hardship on Cancer Presentation and Survival Among Patients with Testicular Germ Cell Tumors - Beyond the Abstract

Articles

Editor Selected Abstracts and Commentaries

Male Infertility

Aging Remodels Mitochondrial Architecture Across the Male Reproductive Axis.

Biallelic Variants of CHTF18 Are Associated With Male Infertility With Cryptozoospermia in Humans.

Endocrine Disruption and Male Fertility.

Peyronie's Disease

Plaque incision and grafting for peyronie's disease: 15-year experience and functional outcomes from a high-volume andrology centre.

Erectile Dysfunction

A Single-Centre Clinical Audit of Erectile Dysfunction Assessment and Management in UK General Practice Against National Guidelines.

Systematic review on the safety and effectiveness of restorative therapies for erectile dysfunction.

Restoring sexual health and relationship quality through penile prosthesis implantation.

Predictors of penile prosthesis length: results from the PHOENIX registry.

Erectile dysfunction in primary care: practice patterns, barriers, and opportunities-narrative review.

Phytotherapies and Complementary Therapies for Erectile Dysfunction: A Focused Secondary Synthesis and Critical Clinical Interpretation of the AFU/SFMS Evidence Base.

BPH - Benign Prostatic Enlargement

Artificial Intelligence as a Diagnostic Tool for Benign Prostatic Hyperplasia (BPH): A Narrative Review.

Endoscopic enucleation for prostate volumes ≥ 200 ml: current evidence, technical challenges, and clinical implications.

Elevated Risk of Acute Urine Retention in Patients with Symptomatic Benign Prostate Hyperplasia Following Coronavirus Disease 2019 Infection: A Retrospective Cohort Study from TriNetX.

Transurethral anatomical enucleation of the prostate using a 1470-nm diode laser (DiLEP) versus transurethral resection of the prostate (TURP) for large-volume benign prostatic hyperplasia: a prospective randomized controlled trial.

Penile & Urethral Cancers

Single-cell immunoprofiling reveals a dysfunctional-like immune microenvironment and malignant phenotype in aging penile squamous cell carcinoma.

Danish National Penile Cancer Database, DaPeCa-Data: Characteristics, Management, and Survival 2000-2025 - Beyond the Abstract

Testicular Cancer

Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors study.

Spontaneous miscarriage after intracytoplasmic sperm injection with frozen sperm of patients with testicular germ cell tumour.

Integrating the relevance of sleep into testicular-cancer survivorship care.

Prostate Cancer

Outcomes of Patients With Favorable Intermediate Risk Gleason Grade Group 2 Prostate Cancer Undergoing Radical Prostatectomy in the MRI Era: Refining Active Surveillance Selection Criteria.

Neuroendocrine Transformation Without PSA Elevation in High-Risk Metastatic Castration-Sensitive Prostate Cancer Under Androgen Receptor Signaling Inhibition: A Case Report.

High folate receptor expression is associated with aggressive features in prostate cancer with low prostate-specific membrane antigen expression.

Progression-free Survival Following Primary Staging with [18F]PSMA-1007-PET/ceCT Versus Na[18F]F-PET/ceCT in Prostate Cancer: Results from the PRISMA-PET Randomized Controlled Trial.

Younger Age Is Associated With Early Urinary Continence Recovery After Robot-Assisted Radical Prostatectomy.

Aglatimagene Besadenovec (CAN-2409) with Radiotherapy for Patients with Localised Prostate Cancer: A Phase 3, Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial - Beyond the Abstract

Artera Expands Its Validated Multimodal AI Platform to Metastatic Hormone‑Sensitive Prostate Cancer (mHSPC)

Prospective Multicenter Randomized Controlled Trial of Stabilized Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: 3-Year Results

A decision-oriented framework for genomic testing across the prostate cancer continuum.

Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer.

Years of life lost from metastatic prostate cancer according to household income.

Enhancing foundation model transfer for prostate cancer detection with patch-level contrastive learning.

Deep learning models built from PSMA PET of the primary tumor can predict synchronous and metachronous prostate cancer metastases.

Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate Cancer.

Adding Immunotherapy to Radiation Improves Disease-Free Survival in Localized Prostate Cancer

Clinico-genomic nomograms for estimation of survival risk in metastatic castrate-resistant prostate cancer.

Focal Cryo-ablation for Treatment of Intermediate Favorable Risk (Grade Group 2) Prostate Cancer.

A harmonized single-cell RNA-seq atlas of human localized and metastatic prostate cancers and benign tissues.

Impact of Prior Treatments on Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer: A Real-World Analysis in the United States.

Progression-free survival following primary staging with [¹⁸F]PSMA-1007-PET/ceCT versus Na[¹⁸F]F-PET/ceCT in prostate cancer: Results from the PRISMA-PET randomized controlled trial

Population-adjusted network meta-analyses provide new insights into the efficacy of treatment alternatives for metastatic castration-sensitive prostate cancer.

USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer.

GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancer.

Comparative functional, perioperative and oncological outcomes of robot-assisted and open radical prostatectomy: a systematic review and meta-analysis.

Beyond GnRH analogues: The Renaissance of Estrogens in Prostate Cancer Management.

Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate Cancer.

One-Year Functional Satisfaction and Quality of Life Outcomes of Patients With a History of Radiotherapy With Artificial Urinary Sphincters.

New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study.

Impact of radiotherapy timing on survival and radiotoxicity outcomes in localized prostate cancer: a retrospective cohort study.

Phase 1b trial of Bavdegalutamide (ARV-110) in combination with Abiraterone for metastatic prostate cancer.

One-year Follow-up after US-guided Transperineal Focal Laser Ablation of Localized Prostate Cancer: Worldwide Registry Study.

Real-World Clinical and Economic Outcomes Among Patients with Localized Prostate Cancer Undergoing Radical Prostatectomy Across Different Risk Stratifications in the United States.

Impact of Absolute PSA Value and Relative PSA Response Rate on Overall Survival in Patients With Metastatic Castration-Sensitive Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors.

Dosimetry Analysis of 177Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial - Beyond the Abstract

Associations Between Medicaid Insurance, Facility Medicaid Share, and Guideline-Concordant Prostate Cancer Care - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC